SOST and type 2 diabetes mellitus: Firstly, the former study used Mendelian randomization to predict the causal effects of sclerostin and T2DM risk, while the latter was a cross-sectional study that was vulnerable to reverse causation, and it did not rule out the confounding effects of medication.